Helsinn manufacturing supports a wide range of chemistry manufacturing and control (CMC) and regulatory activities pertaining to good manufacturing practice (cGMP) production, from clinical trial material to commercial launch and supply. They have manufacturing facilities in Ireland and Switzerland. Helsinn’s manufacturing facilities are consistently upgraded and maintained to remain fully compliant with FDA, EMA, Swissmedic, Japanese PMDA and PIC requirements, which grants them the ability to export to over 50 countries worldwide. Helsinn has more than 30 years’ experience in classical active pharmaceutical ingredients (APIs), including 10 years of experience in High Potency Active Ingredients (HPAPIs) and a late stage pipeline of future cancer therapies.